Package 50090-7702-0

{"route": ["ORAL"], "spl_id": "f0f161b9-6f97-4b3c-ba62-a0ba54b11006", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["4ab809f3-8898-463c-b55a-f452c87d0779"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-7702-0)", "package_ndc": "50090-7702-0", "marketing_start_date": "20251014"}], "brand_name": "Valacyclovir", "product_id": "50090-7702_f0f161b9-6f97-4b3c-ba62-a0ba54b11006", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-7702", "generic_name": "Valacyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20150525", "listing_expiration_date": "20271231"}